Results 151 to 160 of about 6,924,662 (223)
Some of the next articles are maybe not open access.
European Journal of Ophthalmology, 1995
The efficacy and safety of ciprofloxacin (0.3%) ophthalmic solution and rifamycin (1%) ophthalmic solution for the treatment of bacterial conjunctivitis and blepharitis was compared in this randomized, double-masked, parallel-group study. Forty-one patients, 19 on ciprofloxacin and 22 on rifamycin, were culture-positive on admission and evaluated for ...
F. Malet +4 more
openaire +2 more sources
The efficacy and safety of ciprofloxacin (0.3%) ophthalmic solution and rifamycin (1%) ophthalmic solution for the treatment of bacterial conjunctivitis and blepharitis was compared in this randomized, double-masked, parallel-group study. Forty-one patients, 19 on ciprofloxacin and 22 on rifamycin, were culture-positive on admission and evaluated for ...
F. Malet +4 more
openaire +2 more sources
Journal of Ocular Pharmacology and Therapeutics, 2013
PURPOSE To investigate the effect of differently preserved ophthalmic solutions on the viability and barrier function of human corneal epithelial cells (HCEC) using fluorescent dyes.
Manlong Xu, J. Sivak, D. McCanna
semanticscholar +1 more source
PURPOSE To investigate the effect of differently preserved ophthalmic solutions on the viability and barrier function of human corneal epithelial cells (HCEC) using fluorescent dyes.
Manlong Xu, J. Sivak, D. McCanna
semanticscholar +1 more source
Local toxicity of benzalkonium chloride in ophthalmic solutions following repeated applications.
Journal of Toxicological Sciences, 2013We performed repeated toxicity studies of benzalkonium chloride (BAK)-containing vehicles of ophthalmic solutions in monkeys and rabbits to assess the local toxicity of BAK after repeated applications on the ocular surface.
A. Okahara, K. Kawazu
semanticscholar +1 more source
Contact Dermatitis to Ophthalmic Solutions: An Update
Dermatitis®, 2023Eyelid and periorbital dermatitis remains a distressing and recalcitrant disease. Contact dermatitis remains the most common cause of eyelid and periorbital dermatitis. Ophthalmic solutions used in the treatment of ophthalmic conditions can often be the cause.
Sally J. Ashton, Avad A. Mughal
openaire +2 more sources
STABILITY OF PENICILLIN IN OPHTHALMIC SOLUTIONS
Archives of Ophthalmology, 1947IN THE past year several reports have been made concerning the stability of penicillin in solution or in ointment mixture. Gots and Glazer 1 found that specimens of solution and ointment containing 1,000 units per cubic centimeter remain active for approximately one month at room temperature. Kirby 2 found "considerable activity" in an istonic solution
openaire +3 more sources
Antimicrobial activity of a new preservative for multiuse ophthalmic solutions.
Journal of Ocular Pharmacology and Therapeutics, 2013PURPOSE The aim of this study was to examine the antimicrobial activity and the preservative efficacy of a novel preservative solution containing sodium hydroxymethyl glycinate (SHMG) and edetate disodium (EDTA), which is used for preservation of some ...
E. Ghelardi +5 more
semanticscholar +1 more source
The Preparation of Sterile Ophthalmic Solutions
Journal of the American Pharmaceutical Association (Practical Pharmacy ed.), 1953The authors describe an aseptic technique which has been designed to provide the pharmacist with an inexpensive and convenient method of preparing small volumes of sterile solutions in the pharmacy.
Eugene L. Parrott +2 more
openaire +2 more sources
Evaluation of a new preoperative ophthalmic solution
Canadian Journal of Ophthalmology, 2005Maximum mydriasis and corneal clarity during intraocular surgery are important to ensure operational safety. However, repeated instillation of mydriatic and anti-inflammatory ophthalmic solutions during surgery may affect compliance and may damage the corneal epithelium.
Yuko Kamei +4 more
openaire +3 more sources
METHOD FOR THE MAINTENANCE OF STERILITY OF OPHTHALMIC SOLUTIONS
Archives of Ophthalmology, 1947It is well known that the majority of ophthalmic surgeons are suspicious of the sterility of the ophthalmic solutions presented for use during the course of a surgical procedure on the eye and in the postoperative care. This skeptical attitude extends from the confines of the smallest community or private hospital to the marble halls of the greatest ...
Carl F. Jensen, Gilbert N. Haffly
openaire +3 more sources
Ophthalmic Research, 2012
The study used a validated acute in vivo model to compare a new formulation of travoprost 0.004% ophthalmic solution (travoprost PQ), preserved with polyquaternium-1 (PQ), with commercially available formulations of benzalkonium-chloride (BAK)-preserved ...
Hong Liang +3 more
semanticscholar +1 more source
The study used a validated acute in vivo model to compare a new formulation of travoprost 0.004% ophthalmic solution (travoprost PQ), preserved with polyquaternium-1 (PQ), with commercially available formulations of benzalkonium-chloride (BAK)-preserved ...
Hong Liang +3 more
semanticscholar +1 more source